TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

PENNIES FOR HOPE

13 cents a day can save a child

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

TOGETHER WE CAN FIND A CURE

Let's Save the First Child from Duchenne muscular dystrophy

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

Make a difference that lasts a lifetime!

Your donation of only 13¢ a day ($4/month) will help fund our clinical trial.

JAR of Hope is on a mission to set a world record by assembling the largest group to perform 10 squats simultaneously—all in support of children battling Duchenne Muscular Dystrophy.


Why? Because children with Duchenne typically lose the ability to walk by age 12 and will never be able to rise from a chair again. This event is a powerful way to stand—literally and figuratively—with those who no longer can.

GET YOUR TICKETS!

Staten Island Ferry Hawks
May 4, 2025 – 1:30pm
Jersey Shore Blueclaws
May 22, 2025 – 6:35pm
Miami Marlins
June 22, 2025 – 1:40pm
GET YOUR TICKETS

Because no child should have to suffer like this.

Duchenne muscular dystrophy (DMD) is one of the rarest diseases on Earth. DMD is a fatal, muscle-wasting disease you are born with. It occurs once in every 3,500 live births and effects mostly boys. In the United States, with a population of over 330,000,000 people, only about 20,000 children are stricken with Duchenne. And there is no cure.


Our goal is to find a cure for Duchenne muscular dystrophy. With organized fundraising events and support from you, we can continue our mission and turn the dream of finding a cure into a reality.

LEARN MORE

Together, JAR of Hope has

RAISED $7 MILLION+

HELPED OVER 25+ FAMILIES

SPREAD AWARENESS GLOBALLY

Together, JAR of Hope has

RAISED $7 MILLION+

HELPED OVER 25+ FAMILIES

SPREAD AWARENESS GLOBALLY

Duchenne Muscular Dystrophy Clinical Trial 

We have partnered with the University of Florida College of Medicine and RESTEM LLC to to initiate an important trial for Duchenne muscular dystrophy (DMD).


Authorization has been granted to begin Phase 1 of the trial. Here, a "randomized, double-blind, placebo-controlled Cross Over study to assess the safety, tolerability, and preliminary efficacy of Umbilical Cord Lining stem cells (ULSC) in Pediatric patients with Duchenne muscular dystrophy (DMD).”

LEARN MORE ABOUT THE TRIAL

In the News

April 22, 2025
As research into autism spectrum disorder (ASD) continues to evolve, one intriguing area of study is the role of the microbiome—the trillions of microorganisms living in our guts. Emerging evidence suggests that the health of our microbiome may have significant implications for children with autism, particularly in relation to gut disorders and neurological development. This blog explores the connection between the microbiome and autism, emphasizing the importance of detailed stool analyses, checking for parasites, and understanding the gut-brain relationship. What is the Microbiome? The microbiome refers to the vast community of bacteria, viruses, fungi, and other microorganisms that inhabit our digestive systems. These microorganisms play a crucial role in digestion, immunity, and even brain function. In children with autism, studies have indicated that there may be an imbalance in the microbiome, often referred to as dysbiosis. This condition can lead to gastrointestinal issues that are commonly reported in children with ASD, such as constipation, diarrhea, and abdominal pain.
April 10, 2025
A groundbreaking study published in Cell on January 23, 2020, has identified 102 genes associated with autism spectrum disorder (ASD), including 30 previously unlinked to the condition. Led by Joseph Buxbaum, director of the Seaver Autism Center for Research and Treatment at Mount Sinai, the research analyzed over 35,000 DNA samples, nearly 12,000 of which were from individuals with autism. The study leveraged advanced genetic sequencing technologies and data from the Autism Sequencing Consortium, an international collaboration of scientists sharing samples and data since 2010. By comparing genetic sequences from individuals with autism to their siblings and to unaffected individuals, the researchers identified both inherited mutations and spontaneous (de novo) genetic alterations that may contribute to ASD. Notably, the research distinguished genes more closely associated with autism from those linked to other neurodevelopmental disorders, such as intellectual and motor disabilities. This differentiation enhances our understanding of autism's molecular mechanisms and could inform the development of targeted treatments. Dr. Geraldine Dawson, director of the Center for Autism and Brain Development at Duke University, hailed the study as "one of the most important, comprehensive studies on the genetics of autism to date," emphasizing its role in elucidating the complex genetic landscape of ASD. ​ This research represents a significant step forward in autism genetics, offering hope for more personalized and effective interventions in the future. January 24, 2020 2:19 PM EST Time Magazine
April 10, 2025
A new study is shedding light on the potential of CBD to ease behavioral challenges in children with autism. Researchers in Israel found that cannabidiol (CBD), a non-psychoactive compound derived from cannabis, significantly improved symptoms like anxiety, aggression, and restlessness in kids on the spectrum. The peer-reviewed study, published in the journal Translational Psychiatry, followed 82 children and teens with autism who were treated with CBD-rich cannabis oil for six months. Results showed that many experienced meaningful improvements in behavior and social communication — with minimal side effects. Parents reported reduced irritability, fewer outbursts, and better sleep among participants. One mother shared that her nonverbal son began using more words and expressing emotions for the first time. While researchers emphasized that CBD isn’t a cure for autism, they believe it could be a safe and effective option to support children with challenging symptoms — especially when traditional treatments fall short. As interest in alternative therapies grows, this study adds to the growing body of research suggesting that CBD may offer a new avenue of hope for families navigating autism. Published April 8, 2025, 9:46 a.m. ET New York Post
READ THE NEWS